SMT201800644T1 - Processo farmaceutico e intermedi - Google Patents
Processo farmaceutico e intermediInfo
- Publication number
- SMT201800644T1 SMT201800644T1 SM20180644T SMT201800644T SMT201800644T1 SM T201800644 T1 SMT201800644 T1 SM T201800644T1 SM 20180644 T SM20180644 T SM 20180644T SM T201800644 T SMT201800644 T SM T201800644T SM T201800644 T1 SMT201800644 T1 SM T201800644T1
- Authority
- SM
- San Marino
- Prior art keywords
- intermediates
- pharmaceutical process
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919671P | 2013-12-20 | 2013-12-20 | |
| PCT/US2014/071613 WO2015095765A1 (en) | 2013-12-20 | 2014-12-19 | Pharmaceutical process and intermediates |
| EP14828102.5A EP3083648B1 (en) | 2013-12-20 | 2014-12-19 | Pharmaceutical process and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201800644T1 true SMT201800644T1 (it) | 2019-01-11 |
Family
ID=52358996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20180644T SMT201800644T1 (it) | 2013-12-20 | 2014-12-19 | Processo farmaceutico e intermedi |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9388203B2 (it) |
| EP (1) | EP3083648B1 (it) |
| JP (1) | JP6522005B2 (it) |
| CN (1) | CN105849115B (it) |
| CA (2) | CA3186267C (it) |
| CY (1) | CY1121313T1 (it) |
| DK (1) | DK3083648T3 (it) |
| ES (1) | ES2701088T3 (it) |
| HR (1) | HRP20181933T1 (it) |
| HU (1) | HUE042204T2 (it) |
| LT (1) | LT3083648T (it) |
| PL (1) | PL3083648T3 (it) |
| PT (1) | PT3083648T (it) |
| RS (1) | RS58084B1 (it) |
| SI (1) | SI3083648T1 (it) |
| SM (1) | SMT201800644T1 (it) |
| WO (1) | WO2015095765A1 (it) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109912622A (zh) * | 2019-03-20 | 2019-06-21 | 中国药科大学 | 一种福他替尼关键中间体的制备方法及其中间体和利用中间体制备福他替尼的方法 |
| CN118702735B (zh) * | 2024-07-15 | 2025-12-30 | 河北常山生化药业股份有限公司 | 福坦替尼杂质及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0413018B8 (pt) | 2003-07-30 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, e, uso de um composto |
| JP4801096B2 (ja) * | 2005-01-19 | 2011-10-26 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ２，４−ピリミジンジアミン化合物のプロドラッグおよびそれらの使用 |
| WO2008064274A1 (en) * | 2006-11-21 | 2008-05-29 | Rigel Pharmaceuticals, Inc. | Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| UA108077C2 (xx) * | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну | |
| US8389515B2 (en) * | 2009-11-20 | 2013-03-05 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and prodrugs and their uses |
-
2014
- 2014-12-19 CA CA3186267A patent/CA3186267C/en active Active
- 2014-12-19 LT LTEP14828102.5T patent/LT3083648T/lt unknown
- 2014-12-19 HU HUE14828102A patent/HUE042204T2/hu unknown
- 2014-12-19 HR HRP20181933TT patent/HRP20181933T1/hr unknown
- 2014-12-19 JP JP2016560869A patent/JP6522005B2/ja active Active
- 2014-12-19 US US14/576,544 patent/US9388203B2/en active Active
- 2014-12-19 EP EP14828102.5A patent/EP3083648B1/en active Active
- 2014-12-19 CN CN201480069979.6A patent/CN105849115B/zh active Active
- 2014-12-19 ES ES14828102T patent/ES2701088T3/es active Active
- 2014-12-19 PT PT14828102T patent/PT3083648T/pt unknown
- 2014-12-19 CA CA2934535A patent/CA2934535C/en active Active
- 2014-12-19 PL PL14828102T patent/PL3083648T3/pl unknown
- 2014-12-19 SI SI201430992T patent/SI3083648T1/sl unknown
- 2014-12-19 WO PCT/US2014/071613 patent/WO2015095765A1/en not_active Ceased
- 2014-12-19 SM SM20180644T patent/SMT201800644T1/it unknown
- 2014-12-19 DK DK14828102.5T patent/DK3083648T3/en active
- 2014-12-19 RS RS20181453A patent/RS58084B1/sr unknown
-
2016
- 2016-06-10 US US15/178,967 patent/US9695204B2/en active Active
-
2018
- 2018-12-04 CY CY20181101287T patent/CY1121313T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3083648T (lt) | 2019-01-25 |
| CN105849115A (zh) | 2016-08-10 |
| CA3186267A1 (en) | 2015-06-25 |
| US9695204B2 (en) | 2017-07-04 |
| PT3083648T (pt) | 2018-12-14 |
| CY1121313T1 (el) | 2020-05-29 |
| US20160355531A1 (en) | 2016-12-08 |
| CA3186267C (en) | 2025-09-09 |
| CA2934535A1 (en) | 2015-06-25 |
| PL3083648T3 (pl) | 2019-05-31 |
| EP3083648B1 (en) | 2018-09-12 |
| JP6522005B2 (ja) | 2019-05-29 |
| WO2015095765A1 (en) | 2015-06-25 |
| HUE042204T2 (hu) | 2019-06-28 |
| CN105849115B (zh) | 2019-06-11 |
| JP2017503018A (ja) | 2017-01-26 |
| EP3083648A1 (en) | 2016-10-26 |
| CA2934535C (en) | 2023-03-28 |
| US9388203B2 (en) | 2016-07-12 |
| US20150175639A1 (en) | 2015-06-25 |
| HRP20181933T1 (hr) | 2019-01-11 |
| SI3083648T1 (sl) | 2019-02-28 |
| ES2701088T3 (es) | 2019-02-20 |
| DK3083648T3 (en) | 2019-01-07 |
| RS58084B1 (sr) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3015467T3 (da) | Morpholino-oligonukleotidfremstillingsfremgangsmåde | |
| BR112016009485A2 (pt) | Inalador de medicamento | |
| DK2943561T3 (da) | Fotobioreaktor | |
| IL243728A0 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| SI2991633T1 (sl) | Terapija za bakteriofagi | |
| BR112015021083A2 (pt) | método | |
| DK3590499T3 (da) | Inhalerbare lægemidler | |
| FI20135866L (fi) | Mikrobiologinen keratiinin prosessointi | |
| EP3086897C0 (en) | WELDING ASSEMBLY AND METHOD | |
| BR112015029076A2 (pt) | método | |
| EP3048883C0 (en) | PESTICIDE COMPOSITION AND ASSOCIATED PROCESS | |
| LT3079667T (lt) | Farmacinės vaisto formos | |
| DK3047028T5 (da) | Fermenteringsfremgangsmåde | |
| HUE051592T2 (hu) | Kezelési módszer | |
| SMT201800644T1 (it) | Processo farmaceutico e intermedi | |
| DK3041506T3 (da) | Behandlingsfremgangsmåde | |
| TH1501000332A (th) | ฟลูออโรพิโคลิโนอิล ฟลูออไรด์และกระบวนการเตรียม | |
| TH1401006300A (th) | กระบวนการหมัก | |
| BR302013006611S1 (pt) | Configuração aplicada em brinco | |
| SM201300005S (it) | Ciondoli | |
| BR302013003714S1 (pt) | Configuração aplicada em brinco | |
| ES1092107Y (es) | Pulsera compuesta | |
| ES1086729Y (es) | Pulsera perfeccionada | |
| CU20130009S4 (es) | Adorno | |
| BR302013005065S1 (pt) | Configuração aplicada em entressola |